Discovery Laboratories (DSCO) To Present At The 25th Annual Piper Jaffray Health Care Conference
11/21/2013 7:07:50 AM
More...
|
Discovery Laboratories (DSCO) Receives FDA Clearance Of IND To Initiate AEROSURF® Phase 2 Clinical Program
11/13/2013 10:46:20 AM
More...
|
Discovery Laboratories (DSCO) Reports Third Quarter 2013 Financial Results
11/13/2013 9:42:56 AM
More...
|
Discovery Laboratories (DSCO) Announces U.S. Commercial Launch of SURFAXIN® (lucinactant)
11/8/2013 10:01:54 AM
More...
|
Discovery Laboratories (DSCO) to Host Conference Call to Discuss Third Quarter 2013 Results on Wednesday, November 13, 2013
11/8/2013 7:28:21 AM
More...
|
Discovery Laboratories (DSCO) Announces Completion of $50 Million Public Offering
11/6/2013 9:59:00 AM
More...
|
Discovery Laboratories (DSCO) Announces Proposed Public Offering of Common Stock
10/31/2013 10:10:03 AM
More...
|
Discovery Laboratories (DSCO) Prices $50 Million Public Offering of Common Stock
10/31/2013 7:21:57 AM
More...
|
Discovery Laboratories (DSCO) Announces IND Submission for AEROSURF®
10/18/2013 9:08:39 AM
More...
|
Discovery Laboratories (DSCO) Announces Notice of Allowance for a U.S. Patent Supporting the AEROSURF® Development Program
10/8/2013 9:32:40 AM
More...
|
|